In a male patient who had a transurethral resection of the prostate 4 weeks ago and now presents with pyelonephritis, leukocytosis (white blood cell count 24 × 10⁹/L) and a urine culture that shows no growth after 72 hours, what empiric broad‑spectrum intravenous antibiotic regimen should be initiated?

Empiric Antibiotic Management for Post-TURP Pyelonephritis with Culture-Negative Bacteremia

Immediate Empiric Regimen

In a male patient 4 weeks post-TURP presenting with pyelonephritis, leukocytosis (WBC 24 × 10⁹/L), and culture-negative bacteremia after 72 hours, initiate empiric broad-spectrum intravenous therapy with ceftriaxone 2 g IV once daily plus gentamicin 5 mg/kg IV once daily, then transition to oral levofloxacin 750 mg once daily for a total 14-day course once clinically stable. 1

This recommendation prioritizes the high risk of multidrug-resistant organisms in post-instrumentation patients while accounting for the culture-negative status that may reflect prior antibiotic exposure or fastidious organisms. 1

Rationale for Dual Initial Therapy

• Ceftriaxone 2 g IV once daily provides excellent urinary concentrations and broad-spectrum coverage against common uropathogens including E. coli, Proteus, and Klebsiella, which are the most frequent pathogens in complicated UTIs. 1

• Adding gentamicin 5 mg/kg IV once daily as consolidated 24-hour dosing enhances gram-negative coverage, particularly for potential ESBL-producing organisms or Pseudomonas, which are more prevalent in patients with pre-operative indwelling catheters. 1

• Patients with pre-operative indwelling urinary catheters exhibit a higher prevalence of multidrug-resistant organisms, including ESBL-producing Enterobacteriaceae, after TURP, necessitating broader initial empiric coverage. 1

Culture-Negative Bacteremia: Clinical Implications

• The absence of growth after 72 hours suggests either prior antibiotic exposure (which reduces blood culture sensitivity by approximately 50%), fastidious organisms, or adequate source control from the urinary tract. 2

• When blood cultures remain negative after 72–96 hours in a patient receiving appropriate empirical therapy, discontinue empirical vancomycin if it was started, as current guidelines restrict prolonged empirical use of this agent. 3

• Blood cultures in febrile UTIs rarely provide additional useful information compared to urine cultures alone when urine cultures are positive; however, in culture-negative scenarios with high fever and complicated infection, the blood culture result (even if negative) helps exclude bacteremia and supports a urinary-source diagnosis. 4

Transition to Oral Therapy

• Switch to oral levofloxacin 750 mg once daily once the patient has been afebrile for ≥48 hours and is hemodynamically stable; the combined IV-plus-oral regimen should total 14 days. 1

• A 14-day total course is required for male patients when prostatitis cannot be excluded (the usual scenario post-TURP), even with prompt clinical response. 1

• Fluoroquinolones are the preferred oral step-down agents if local resistance is <10% and the patient has no fluoroquinolone exposure in the preceding 3 months. 1

Alternative Oral Step-Down Options

• Trimethoprim-sulfamethoxazole 160/800 mg orally twice daily for 14 days is an appropriate alternative when fluoroquinolones are contraindicated or unavailable, provided the pathogen (if identified) is susceptible. 1

• Oral cephalosporins (e.g., cefpodoxime 200 mg twice daily for 10 days) have a 15–30% higher failure rate compared with fluoroquinolones and should be reserved for situations where preferred agents are unavailable. 1

Critical Management Steps

• Obtain repeat urine culture if not already done, as the initial culture may have been obtained after antibiotic administration, which significantly reduces sensitivity. 2

• Assess for underlying urological abnormalities (obstruction, incomplete bladder emptying, residual prostatic tissue) because antimicrobial therapy alone is insufficient without source control. 1

• If fever persists beyond 72 hours despite appropriate antibiotic therapy, obtain imaging (ultrasound or CT) to exclude prostatic abscess, perinephric abscess, or urinary obstruction. 1

Common Pitfalls to Avoid

• Do not apply the 7-day duration recommended for uncomplicated pyelonephritis in women; post-TURP infections in men require 14 days because prostatitis cannot be definitively excluded. 1

• Do not use nitrofurantoin or fosfomycin for complicated UTIs or when upper-tract involvement is suspected, as these agents have insufficient tissue penetration. 1

• Do not treat asymptomatic bacteriuria if it develops later; therapy is indicated only for symptomatic infections. 1

• Avoid aminoglycosides beyond the initial 48–72 hours once clinical stability is achieved, to minimize nephrotoxicity risk, especially in elderly patients. 1

Monitoring and Reassessment

• Reassess at 72 hours; lack of clinical improvement (persistent fever, worsening leukocytosis) should prompt consideration of imaging for complications, therapy extension, or urologic consultation. 1

• Inadequate empirical antibiotic therapy is independently associated with increased mortality (adjusted OR 1.46,95% CI 1.28–1.66), emphasizing the importance of broad initial coverage in this high-risk population. 5